期刊文献+

超重、肥胖对2型糖尿病患者凝血及代谢指标的影响(英文) 被引量:7

Influence of obesity and overweight on blood coagulation and metabolic indexes in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的:了解超重、肥胖对2型糖尿病患者凝血及代谢紊乱的影响。方法:选择初诊为2型糖尿病的患者248例,根据人体质量指数(BMI)分为正常BMI对照组(95例)、超重组(87例)、肥胖组(66例),均测定血脂、血糖、空腹胰岛素等相关指标,计算胰岛素抵抗指数(HOMA-IR),并进行统计学处理。结果:与正常BMI对照组相比,超重组、肥胖组血浆纤维蛋白原(fg)[(3.37±0.55)g/L比(4.04±0.70)g/L比(5.20±0.69)g/L]、尿微量白蛋白(UMA)[(14.46±8.90)mg/g比(47.33±42.54)mg/g比(104.45±60.78)mg/g]、空腹血糖(FBG)[(7.15±0.97)mmol/L比(8.84±1.81)mmol/L比(10.06±2.28)mmol/L]、空腹胰岛素(FINS)[(10.09±8.21)IU/ml比(14.33±15.55)IU/ml比(19.69±10.86)IU/ml]、HOMA-IR[(3.19±2.59)比(5.51±5.38)比(8.48±4.62)]及血甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)水平均明显升高,且随肥胖程度的增加而呈上升趋势,而血浆凝血酶原时间(PPT)[(13.33±0.69)s比(12.74±0.69)s比(11.43±0.53)s]、血浆活化部分凝血活酶时间(APTT)[(37.32±2.31)s比(36.55±2.41)s比(34.61±1.53)s]、HDL-C[(1.54±1.12)mmol/L比(1.27±0.41)mmol/L比(1.09±0.28)mmol/L]水平均明显降低,且随肥胖程度的加深而呈下降趋势(P均<0.05)。结论:超重及肥胖加重2型糖尿病凝血功能及代谢障碍,并加重胰岛素抵抗的程度,且此异常随肥胖程度的加深而更加严重。 Objective:To study influence of overweight and obesity on blood coagulation and metabolic disorders in patients with type 2 diabetes mellitus(T2DM).Methods: total of 248 preliminary diagnosed T2DM patients were selected.According to body mass index(BMI),they were divided into normal BMI control group(n=95),overweight group(n=87) and obesity group(n=66).Blood lipids,blood glucose and fasting insulin(FINS) were measured in all patients and homeostasis model-insulin resistance index(HOMA-IR) was calculated then.Statistical analysis was performed.Results:Compared with normal BMI control group,there were significant increase in fibrinogen [(3.37±0.55) g/L vs.(4.04±0.70) g/L vs.(5.20±0.69) g/L],urine microalbumin [(14.46±8.90) mg/g vs.(47.33±42.54) mg/g vs.(104.45±60.78) mg/g],fasting blood glucose [(7.15±0.97) mmol/L vs.(8.84±1.81) mmol/L vs.(10.06±2.28) mmol/L],FINS [(10.09±8.21) IU/ml vs.(14.33±15.55) IU/ml vs.(19.69±10.86) IU/ml],HOMA-IR[(3.19±2.59) vs.(5.51±5.38) vs.(8.48±4.62)],TG,TC and LDL-C levels in overweight group and obesity group,and the more BMI patients were,the higher these indicators were;There were significant decrease in plasma prothrombin time [(13.33±0.69)s vs.(12.74±0.69)s vs.(11.43±0.53)s],activated partial thromboplastin time [(37.32±2.31)s vs.(36.55±2.41)s vs.(34.61±1.53)s] and HDL-C [(1.54±1.12) mmol/L vs.(1.27±0.41) mmol/L vs.(1.09±0.28) mmol/L] in overweight group and obesity group(P0.05 all).Conclusion:Overweight and obesity aggravate coagulation and metabolic disorders in patients with type 2 diabetes mellitus.It also aggravates degree of insulin resistance,the more BMI patients are,the more serious they are.
出处 《心血管康复医学杂志》 CAS 2012年第2期125-129,共5页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 Scientific and technological project in Liaoning Province(2011225052-2011020216-428)~~
关键词 糖尿病 2型 肥胖症 凝血酶原 高脂血症 Diabetes mellitus type 2 Obesity Blood lipid Hyperlipidemia
  • 相关文献

参考文献4

二级参考文献56

  • 1刘珉,刘伟.FOXC2的研究进展[J].上海第二医科大学学报,2005,25(7):757-760. 被引量:6
  • 2Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches[J]. Med Clin North Am,2009,93(3):733-751.
  • 3Janghorbani M, Amini M, Willett WC, et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults[J]. Obesity (Silver Spring),2007,15(11):2797-2808.
  • 4World Health Organization. Global Strategies on Diet, Physical Activity and Health[C]. 2006[2009-06-01]. http //www.who.int/dietphysicalactivity/publications/facts/obesity/en/.
  • 5Geloneze B, Pereira JA, Pareja JC, et al. Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass[J]. Arq Bras Endocrinol Metabol,2009,53(2):293-300.
  • 6Dyck DJ. Adipokines as regulators of muscle metabolism and insulin sensitivity[J]. Appl Physiol Nutr Metab,2009, 34(3):396-402.
  • 7Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin- 6 in 3T3-L1 adipocytes[J]. Biochem Biophys Res Commun,2003,301(4):1045-1050.
  • 8Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?[J]. Hepatology,2009,49(6):1896-1903.
  • 9Bonen A. PGC-lalpha-induced improvements in skeletal muscle metabolism and insulin sensitivity[J]. Appl Physiol Nutr Metab,2009,34(3):307-314.
  • 10Villela NR, Kramer-Aguiar LG, Bottino DA, et al. Metabolic disturbances linked to obesity: the role of impaired tissue perfusion[J]. Arq Bras Endocrinol Metabol, 2009,53(2):238-245.

共引文献38

同被引文献57

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部